The model to cancer treatment diverges significantly between the United States and Europe . In the US , access treatment is often associated to private health plans, causing in frequently high costs and inconsistent outcomes . Conversely , European systems generally offer … Read More

The transatlantic healthcare landscape presents a complex tapestry of diverse approaches to cancer care. While both the United States and Europe boast remarkable advancements in oncology, significant discrepancies exist in their respective architectures. This article delves into these gaps, exploring the factors contributing them and highlightin… Read More